Discover Remidio's Neubo 130, a groundbreaking AI-driven retinal imaging device enabling real-time diagnosis of neonatal eye conditions like Retinopathy of Prematurity (ROP).

InspireMD (Nasdaq:NSPR) announced today that it appointed Dr. Peter A. Soukas as its new chief medical officer.

Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Sean Lyden, Dr. Joseph Campbell, and Dr.

Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic partnerships with ...

Discover the Apple Vision Pro M5, a $3,500 headset redefining spatial computing with the M5 chip, Vision OS 26, and immersive media features.

In addition to its varying levels of intensity for steady white light, the device has three red-light modes to signal ... or ...

Now in its eighth year, Design World’s LEAP Awards showcase the best engineering innovations across several design categories ...

As a fully integrated system, it reduces the need for additional devices, thereby improving procedural workflows ... FLEX VP is designed to optimise vessel preparation and access management ahead of ...

Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced 24-month efficacy findings from the non-randomized AVG cohort of the WAVE trial. Results of the ...

At 24 months, the access circuit primary patency (ACPP)2 was 25.7% ...

Meta expands AI investment, boosting ad revenue and Reels growth while building long-term monetization and new revenue streams. Learn why META stock is a buy.

The 37th Annual Transcatheter Cardiovascular Therapeutics (TCT2025) symposium was held grandly in San Francisco, USA, attracting widespread attention from the global cardiovascular community. On the ...